Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination of Circulating Tumour DNA and 18F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective Study.
Fiala O, Baxa J, Svaton M, Benesova L, Ptackova R, Halkova T, Minarik M, Hosek P, Buresova M, Finek J, Ferda J, Pesek M. Fiala O, et al. Among authors: pesek m. Cancer Genomics Proteomics. 2022 Mar-Apr;19(2):270-281. doi: 10.21873/cgp.20319. Cancer Genomics Proteomics. 2022. PMID: 35181593 Free PMC article.
Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment.
Krejci D, Opalka P, Krejci J, Zemanova M, Zemanova P, Kultan J, Fischer O, Skrickova J, Bratova M, Cernovska M, Hrnciarik M, Coupkova H, Hurdalkova K, Barinova M, Koubkova L, Dolezal D, Safanda M, Pesek M, Svaton M. Krejci D, et al. Among authors: pesek m. Anticancer Res. 2021 May;41(5):2597-2603. doi: 10.21873/anticanres.15039. Anticancer Res. 2021. PMID: 33952489
Prognostic Value of EGFR Exon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer.
Skrickova J, Pesek M, Opalka P, Koubkova L, Zemanova M, Hrnciarik M, Blazek J, Svaton M, Krejci J, Coupkova H, Dolezal D, Tuzova T, Holubec L, Mahadevia P, Sandstrom K, Kunovszki P, Barinova M, Hurdalkova K, Fischer O, Cernovska M, Bratova M. Skrickova J, et al. Among authors: pesek m. Anticancer Res. 2021 Nov;41(11):5625-5634. doi: 10.21873/anticanres.15378. Anticancer Res. 2021. PMID: 34732435
Detection and Quantification of ctDNA for Longitudinal Monitoring of Treatment in Non-Small Cell Lung Cancer Patients Using a Universal Mutant Detection Assay by Denaturing Capillary Electrophoresis.
Benesova L, Ptackova R, Halkova T, Semyakina A, Svaton M, Fiala O, Pesek M, Minarik M. Benesova L, et al. Among authors: pesek m. Pathol Oncol Res. 2022 Jun 28;28:1610308. doi: 10.3389/pore.2022.1610308. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35837614 Free PMC article.
Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy.
Fiala O, Pesek M, Skrickova J, Kolek V, Salajka F, Tomiskova M, Satankova M, Kultan J, Kuliskova J, Svaton M, Hrnciarik M, Hejduk K, Chloupkova R, Topolcan O, Hornychova H, Nova M, Ryska A, Finek J. Fiala O, et al. Among authors: pesek m. Tumour Biol. 2017 Feb;39(2):1010428317691186. doi: 10.1177/1010428317691186. Tumour Biol. 2017. PMID: 28218046 Free article.
Real-life effectiveness of first-line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry.
Brat K, Bratova M, Skrickova J, Barinova M, Hurdalkova K, Pesek M, Havel L, Koubkova L, Hrnciarik M, Krejci J, Fischer O, Zemanova M, Coupkova H, Svaton M. Brat K, et al. Among authors: pesek m. Thorac Cancer. 2020 Nov;11(11):3346-3356. doi: 10.1111/1759-7714.13679. Epub 2020 Oct 5. Thorac Cancer. 2020. PMID: 33016001 Free PMC article.
Prognostic significance of TIMP-1 in non-small cell lung cancer.
Pesta M, Kulda V, Kucera R, Pesek M, Vrzalova J, Liska V, Pecen L, Treska V, Safranek J, Prazakova M, Vycital O, Bruha J, Holubec L, Topolcan O. Pesta M, et al. Among authors: pesek m. Anticancer Res. 2011 Nov;31(11):4031-8. Anticancer Res. 2011. PMID: 22110238
Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study.
Pazdiora P, Svobodova S, Fuchsova R, Kucera R, Prazakova M, Vrzalova J, Narsanska A, Strakova M, Treskova I, Pecen L, Treska V, Holubec L Jr, Pesek M, Finek J, Topolcan O. Pazdiora P, et al. Among authors: pesek m. Anticancer Res. 2011 Oct;31(10):3619-21. Anticancer Res. 2011. PMID: 21965787
Tumor markers in pleural effusions.
Topolcan O, Holubec L, Polivkova V, Svobodova S, Pesek M, Treska V, Safranek J, Hajek T, Bartunek L, Rousarova M, Finek J. Topolcan O, et al. Among authors: pesek m. Anticancer Res. 2007 Jul-Aug;27(4A):1921-4. Anticancer Res. 2007. PMID: 17649796 Free article.
Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial.
Zatloukal P, Petruzelka L, Zemanová M, Kolek V, Skricková J, Pesek M, Fojtů H, Grygárková I, Sixtová D, Roubec J, Horenková E, Havel L, Průsa P, Nováková L, Skácel T, Kůta M. Zatloukal P, et al. Among authors: pesek m. Lung Cancer. 2003 Sep;41(3):321-31. doi: 10.1016/s0169-5002(03)00233-2. Lung Cancer. 2003. PMID: 12928123 Clinical Trial.
Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial.
Zemanova M, Cernovska M, Havel L, Bartek T, Lukesova S, Jakesova J, Vanasek J, Reiterer P, Kultan J, Andrasina I, Siskova L, Koubkova L, Skrickova J, Salajka F, Pesek M, Klepetko P, Beniak J, Fricke H, Kadlecova P, Korolkiewicz RP, Hraska M, Bartunkova J, Spisek R. Zemanova M, et al. Among authors: pesek m. Cancer Treat Res Commun. 2021;28:100427. doi: 10.1016/j.ctarc.2021.100427. Epub 2021 Jun 26. Cancer Treat Res Commun. 2021. PMID: 34284344 Free article. Clinical Trial.
[Immunotherapy in the Treatment of Lung Cancer].
Fiala O, Šorejs O, Pešek M, Fínek J. Fiala O, et al. Among authors: pesek m. Klin Onkol. 2017 Winter;30(Supplementum3):22-31. doi: 10.14735/amko20173S22. Klin Onkol. 2017. PMID: 29239189 Review. Czech.
[EGFR mutations in patients with advanced NSCLC].
Fiala O, Pešek M, Fínek J, Brůha F, Bortlíček Z, Krejčí J, Benešová L, Minárik M. Fiala O, et al. Among authors: pesek m. Klin Onkol. 2012;25(4):267-73. Klin Onkol. 2012. PMID: 22920167 Czech.
Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database.
Ptáková N, Martínek P, Holubec L, Janovský V, Vančurová J, Grossmann P, Navarro PA, Rodriguez Moreno JF, Alaghehbandan R, Hes O, Májek O, Pešek M, Michal M, Ondič O. Ptáková N, et al. Among authors: pesek m. Genes Chromosomes Cancer. 2021 Jul;60(7):474-481. doi: 10.1002/gcc.22942. Epub 2021 Feb 24. Genes Chromosomes Cancer. 2021. PMID: 33583086
Therapy of small cell lung cancer with emphasis on oral topotecan.
Pirker R, Berzinec P, Brincat S, Kasan P, Ostoros G, Pesek M, Plāte S, Purkalne G, Rooneem R, Skricková J, Stanculeanu D, Timcheva C, Tzekova V, Zakotnik B, Zielinski CC, Zwitter M. Pirker R, et al. Among authors: pesek m. Lung Cancer. 2010 Oct;70(1):7-13. doi: 10.1016/j.lungcan.2010.05.020. Epub 2010 Jun 23. Lung Cancer. 2010. PMID: 20576312 Review.
Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial.
Gatzemeier U, Pluzanska A, Szczesna A, Kaukel E, Roubec J, De Rosa F, Milanowski J, Karnicka-Mlodkowski H, Pesek M, Serwatowski P, Ramlau R, Janaskova T, Vansteenkiste J, Strausz J, Manikhas GM, Von Pawel J. Gatzemeier U, et al. Among authors: pesek m. J Clin Oncol. 2007 Apr 20;25(12):1545-52. doi: 10.1200/JCO.2005.05.1474. J Clin Oncol. 2007. PMID: 17442998 Clinical Trial.
Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study.
Crinò L, Cappuzzo F, Zatloukal P, Reck M, Pesek M, Thompson JC, Ford HE, Hirsch FR, Varella-Garcia M, Ghiorghiu S, Duffield EL, Armour AA, Speake G, Cullen M. Crinò L, et al. Among authors: pesek m. J Clin Oncol. 2008 Sep 10;26(26):4253-60. doi: 10.1200/JCO.2007.15.0672. J Clin Oncol. 2008. PMID: 18779612 Clinical Trial.
[The TULUNG clinical registry].
Spelda S, Skřičková J, Bortlíček Z, Hejduk K, Pešek M, Zatloukal P, Kolek V, Salajka F, Koubková L, Tomíšková M, Grygárková Y, Havel L, Hrnčiarik M, Zemanová M, Sixtová D, Roubec J, Coupková H, Košatová K. Spelda S, et al. Among authors: pesek m. Klin Onkol. 2012;25(5):383-4. Klin Onkol. 2012. PMID: 23102201 Czech. No abstract available.
[TARCEVA Clinical Registry].
Skricková J, Pesek M, Zatloukal P, Kolek V, Salajka F, Koubková L, Krejcí J, Tomísková M, Grygárková Y, Havel L, Hrnciarik M, Skalová B, Stícha M. Skricková J, et al. Among authors: pesek m. Klin Onkol. 2010;23(5):361-3. Klin Onkol. 2010. PMID: 21061685 Czech. No abstract available.
[Radiotherapy of Lung Tumours in Idiopathic Pulmonary Fibrosis].
Kolek V, Vašáková M, Šterclová M, Cwiertka K, Vrána D, Kudláček A, Skřičková J, Pešek M, Petera J. Kolek V, et al. Among authors: pesek m. Klin Onkol. 2017 Summer;30(4):303-306. doi: 10.14735/amko2017303. Klin Onkol. 2017. PMID: 28832178 Review. Czech.
[The International Association for the Study of Lung Cancer Staging Project. Prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer].
Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P; International Staging Committee and Participating Institutions. Chansky K, et al. Zhongguo Fei Ai Za Zhi. 2010 Jan;13(1):9-18. doi: 10.3779/j.issn.1009-3419.2010.01.02. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20672697 Free PMC article. Chinese.
Octreotide in the treatment of malignant thymoma - Case report.
Sorejs O, Pesek M, Finek J, Fiala O. Sorejs O, et al. Among authors: pesek m. Rep Pract Oncol Radiother. 2020 Nov-Dec;25(6):882-885. doi: 10.1016/j.rpor.2020.08.012. Epub 2020 Aug 25. Rep Pract Oncol Radiother. 2020. PMID: 32982594 Free PMC article.
Erlotinib in the treatment of advanced squamous cell NSCLC.
Fiala O, Pesek M, Finek J, Krejci J, Havel L, Hrnciarik M, Salajka F, Bortlicek Z, Benesova L, Minarik M. Fiala O, et al. Among authors: pesek m. Neoplasma. 2013;60(6):676-82. doi: 10.4149/neo_2013_086. Neoplasma. 2013. PMID: 23906302
[Cancer multiplicities in the Czech population].
Geryk E, Dítĕ P, Kozel J, Kubícek P, Konecný M, Stampach R, Pesek M. Geryk E, et al. Among authors: pesek m. Cas Lek Cesk. 2010;149(4):178-83. Cas Lek Cesk. 2010. PMID: 20518251 Czech.
[Adjuvant therapy of lung cancer].
Pesek M, Kohoutková L, Kotorová E, Sefrna F. Pesek M, et al. Cas Lek Cesk. 1990 Feb 9;129(6):179-83. Cas Lek Cesk. 1990. PMID: 2331735 Czech.
[A rare case of bronchial mucoepidermoid tumor].
Hájek M, Novák K, Mukensnábl P, Brůha F, Pesek M. Hájek M, et al. Among authors: pesek m. Rozhl Chir. 1998 Aug;77(8):339-42. Rozhl Chir. 1998. PMID: 9828652 Czech.
[Dependence of chronic bronchitis on body weight].
Simecková B, Simecek C, Pesek M. Simecková B, et al. Among authors: pesek m. Vnitr Lek. 1978 May;24(5):431-4. Vnitr Lek. 1978. PMID: 664370 Czech. No abstract available.
178 results